1. MRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials. Issue 25 (31st May 2019) Authors: Feldman, Robert A.; Fuhr, Rainard; Smolenov, Igor; (Mick) Ribeiro, Amilcar; Panther, Lori; Watson, Mike; Senn, Joseph J.; Smith, Mike; Almarsson, Ӧrn; Pujar, Hari S.; Laska, Michael E.; Thompson, James; Zaks, Tal; Ciaramella, Giuseppe Journal: Vaccine Issue: Volume 37:Issue 25(2019) Page Start: 3326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗